TMRW Life Sciences, Inc.

NEW YORK, NY · Founded 2018 · Medtech · Acquired

Automated cryopreservation system for fertility storage (eggs, sperm, embryos)

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · tmrwlifesciences.com

Sector
Medtech
Headquarters
NEW YORK, NY
Founded
2018
Latest Form D
$38.4M, Apr 2026
Total capital
$196M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$196M
5 Form D · last Apr 2026
6 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
19
21 pending · first 2021
Rank in peer group#115 of 1112

Capital timeline

20192020202120222023202420252026FEDERAL ↑EQUITY ↓Cumulative $196M1st Form D$29M3rd Form D$80.2M4th Form D$28.2M5th Form D$38.4M
2019202120232025FEDERAL ↑EQUITY ↓Cumulative $196M3rd Form D$80.2M

Latest events

  • Private capital raisedForm D · SEC · 5th filing$38.4M
  • Private capital raisedForm D · SEC · 4th filing$28.2M
  • Private capital raisedForm D · SEC · 3rd filing$80.2M
  • Private capital raisedForm D · SEC · 2nd filing$20M
  • Private capital raisedForm D · SEC · 1st filing$29M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#115 · top 10%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Alan Drabant MurrayDirectorNamed in SEC Form D filings
  • Andrew SchwabDirectorNamed in SEC Form D filings
  • Emily Drabant ConleyDirectorNamed in SEC Form D filings
  • Emily Drabant ConleyDirectorNamed in SEC Form D filings
  • Greg EisnerDirectorNamed in SEC Form D filings
  • Jeffrey PortDirectorNamed in SEC Form D filings
Show all 13 people
  • Joshua AbramDirectorNamed in SEC Form D filings
  • Louis Drabant VillabaDirectorNamed in SEC Form D filings
  • Louis VillalbaExecutive Officer, DirectorNamed in SEC Form D filings
  • Roberta MyersDirectorNamed in SEC Form D filings
  • Tara ComonteDirectorNamed in SEC Form D filings
  • Vinay ShahDirectorNamed in SEC Form D filings
  • William SchoolcraftDirectorNamed in SEC Form D filings

What it has protected

USPTO · 19 granted of 40
Show all 40 patent records
  • FEMASYS INCSimilar federal contract value in Medtech · null in contracts
  • GametoSimilar federal contract value in Medtech · null in contracts
  • ATTOGENE CORPORATIONSimilar federal contract value in Medtech · null in contracts
  • CICERODX, INC.Similar federal contract value in Medtech · null in contracts
  • FHC, INC.Similar federal contract value in Medtech · null in contracts
  • APEX ORTHOPAEDIC TECHNOLOGIES LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .